![PDF) Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression | V. Möbus - Academia.edu PDF) Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression | V. Möbus - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/66423497/mini_magick20210425-27988-ckbeo8.png?1619366206)
PDF) Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression | V. Möbus - Academia.edu
Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry | PLOS ONE
Paclitaxel Steady-State Plasma Concentration as a Determinant of Disease Outcome and Toxicity in Lung Cancer Patients Treated wi
![PDF) Nab -paclitaxel Followed by Dose-dense Epirubicin/Cyclophosphamide in Neoadjuvant Chemotherapy for Triple-negative Breast Cancer: A Phase II Study PDF) Nab -paclitaxel Followed by Dose-dense Epirubicin/Cyclophosphamide in Neoadjuvant Chemotherapy for Triple-negative Breast Cancer: A Phase II Study](https://i1.rgstatic.net/publication/365759146_Nab_-paclitaxel_Followed_by_Dose-dense_EpirubicinCyclophosphamide_in_Neoadjuvant_Chemotherapy_for_Triple-negative_Breast_Cancer_A_Phase_II_Study/links/6381cd4248124c2bc6715172/largepreview.png)
PDF) Nab -paclitaxel Followed by Dose-dense Epirubicin/Cyclophosphamide in Neoadjuvant Chemotherapy for Triple-negative Breast Cancer: A Phase II Study
Chemotherapy Immunotherapy Guidelines and Recommendations For Practice 4 | PDF | Chemotherapy | Immunotherapy
![MagicTouch PTA Sirolimus Coated Balloon for Femoropopliteal and Below the Knee Disease: Results From XTOSI Pilot Study Up To 12 Months - Edward Choke, Tjun Yip Tang, Eilane Peh, Karthikeyan Damodharan, Shin MagicTouch PTA Sirolimus Coated Balloon for Femoropopliteal and Below the Knee Disease: Results From XTOSI Pilot Study Up To 12 Months - Edward Choke, Tjun Yip Tang, Eilane Peh, Karthikeyan Damodharan, Shin](https://journals.sagepub.com/cms/10.1177/15266028211064816/asset/images/large/10.1177_15266028211064816-fig1.jpeg)
MagicTouch PTA Sirolimus Coated Balloon for Femoropopliteal and Below the Knee Disease: Results From XTOSI Pilot Study Up To 12 Months - Edward Choke, Tjun Yip Tang, Eilane Peh, Karthikeyan Damodharan, Shin
![IJMS | Free Full-Text | Modulatory Effects of Biosynthesized Gold Nanoparticles Conjugated with Curcumin and Paclitaxel on Tumorigenesis and Metastatic Pathways—In Vitro and In Vivo Studies IJMS | Free Full-Text | Modulatory Effects of Biosynthesized Gold Nanoparticles Conjugated with Curcumin and Paclitaxel on Tumorigenesis and Metastatic Pathways—In Vitro and In Vivo Studies](https://www.mdpi.com/ijms/ijms-23-02150/article_deploy/html/images/ijms-23-02150-g001.png)